Dr. Deepthi Thotakura, MD

Dr. Thotakura practices at Texas Oncology PA in Allen, Texas.

Dr. Thotakura's NPI, 1710369160, was assigned on June 22, 2015. Dr. Thotakura graduated from Texas A&M College of Medicine - Bryan in 2015. Dr. Thotakura holds Texas license R7616.

Dr. Thotakura's primary practice is Texas Oncology PA, at 1105 Central N Expy, Allen, TX 75013 in Collin County. The practice phone is (972) 997-8000.

Dr. Thotakura's primary practice is Texas Oncology PA in Allen, Texas. Dr. Thotakura is also affiliated with Texas Health Presbyterian Hospital Allen. The medical group on file is University of Texas Southwestern Medical Center. Dmand AI also links Dr. Thotakura to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Thotakura practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Thotakura's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Thotakura is board certified in hematology by the American Board of Internal Medicine. Dr. Thotakura is licensed in Texas.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), lung cancer, multiple myeloma and neutropenia among the conditions Dr. Thotakura treats.

CMS data shows 36,217 Medicare services from Dr. Thotakura across 45 procedure codes in 2024, for 354 Medicare patients. Medicare paid $212,208 for them.

CMS counts 354 Medicare patients who saw Dr. Thotakura in 2024. The largest group is 65 to 74, with 155 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 3% are also on Medicaid. Their average risk score is 1.61, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Thotakura's median patient age at 65, with 65% women.

In 2024, Dr. Thotakura wrote 795 Medicare Part D claims for 136 patients. 78% of them were for generic drugs. CMS names the drug for 580 of them, across 20 drugs with 11 or more claims each, at $284,216 in total drug cost. In 2023, CMS named 382 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Thotakura for performance year 2024, reported through an alternative payment model (APM). Dr. Thotakura accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Thotakura as offering telehealth.

Dmand AI links 2 papers to Dr. Thotakura, published from 2018 to 2021. Dr. Thotakura's most frequent co-authors are Hanna Blaney, MD, Charis Durham, MD and Lauren Sisco.

CMS Open Payments shows 192 general payments to Dr. Thotakura from 47 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 59% of the total. Novartis Pharmaceuticals Corporation paid the most, $2,588.

Dr. Thotakura graduated from Texas A&M College of Medicine - Bryan in 2015.

Dr. Thotakura is in network with 24 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 15. Check the plan with the practice before a visit.